Connect with us

Technology

Marani Health and Ouma Health Secure $5 Million CDC Grant with the University of Wisconsin-Madison to Fund Critical Maternal and Child Health Research

Published

4 hours ago

on

CDC Grant will enable new research addressing maternal and child health racial disparities in Wisconsin. 

ST. PAUL, Minn. and AUSTIN, Texas, Oct. 9, 2024 /PRNewswire/ — MARANI HEALTH, a digital and medtech innovation company that sits at the crossroads of maternal health as well as prenatal and postpartum care, and OUMA HEALTH, a cutting-edge maternity telehealth provider that combines world-class clinical services with innovative technology to deliver exceptional care to pregnant individuals—no matter their income or location—announced today that their joint submission to THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) to fund critical research at THE UNIVERSITY OF WISCONSIN–MADISON PREVENTION RESEARCH CENTER, has resulted in a $5 million grant being awarded.

The grant was a joint submission with Marani Health and Ouma Health to fund community-engaged research to address maternal and child health disparities in Wisconsin. The project focuses on reducing racial disparities in maternal and infant health, especially among Black women in Wisconsin who face significantly higher rates of pregnancy-related hypertension and maternal mortality. Pregnancy and face alarming maternal mortality rates three to four times higher than non-Black women.

“We are thrilled to collaborate on this transformative initiative,” said Ann Holder, CEO of Marani Health. “This CDC grant will enable the management of patients outside the walls of hospitals and clinics and allow patients to interact with their clinical team in the comfort of their home.”

“Our partnership represents a meaningful opportunity to leverage our digital health and data technology to address the critical disparities in maternal care and make quality care more accessible to the communities that need it most,” added Holder.

Dr. Sina Haeri, CEO of Ouma Health, emphasized, “We are committed to ensuring that every expectant mother, regardless of her circumstances or location, has access to high-quality maternity care. By partnering with the University of Wisconsin and Marani Health, we can provide real-time, expert care that addresses the immediate needs of high-risk patients and help reduce maternal mortality and other preventable outcomes.”

The primary research project will be led Dr. Kara Hoppe, associate professor of Obstetrics and Gynecology and maternal fetal medicine specialist and Andy Garbzcz, professor in educational psychology at the UW School of Medicine and Public Health. The project will expand Dr. Kara Hoppe’s Staying healthy After Childbirth (STAC) program, which monitors blood pressure during and after pregnancy to reduce complications and hospital readmissions. The program will be adapted to local communities, providing remote support through organizations like doulas and public health departments. The grant will support research, community engagement, and policy development aimed at improving maternal and child health outcomes across Wisconsin.The project will be conducted under the aegis and supervision of the University Of Wisconsin-Madison Prevention Research Center, which is directed by Dr. Jill Denson. Dr. Denson holds a doctorate in public health with a specialization in community and behavioral health promotion. 

Marani Health is revolutionizing maternity care by enabling providers to remotely assess and manage patient risks. Through its cutting-edge technology, Marani Health empowers providers to transform the traditional maternity care model with the goal of improving quality and reducing costs. The platform expands access to care with innovative solutions like remote patient monitoring while addressing health inequities by tackling social determinants of health and mental health issues. Additionally, Marani Health facilitates the implementation of evidence-based care plans at scale and fosters collaboration among multidisciplinary care teams, ensuring comprehensive care for patients.

Ouma Health’s team of Maternal-Fetal Medicine physicians, certified nurse midwives, and perinatal nurse navigators will provide 24/7 maternity telehealth for patients. Ouma’s expertise in diagnosing and treating high-risk patients via remote services ensures continuous, comprehensive care that extends beyond the traditional clinical setting. This integration of telehealth allows the project to reach more patients, providing expert guidance and support throughout pregnancy, delivery, and postpartum care.

Together, Ouma Health’s clinical expertise and Marani’s technology offers two best-in-class solutions that give patients the tools to monitor their health from home while ensuring that clinicians are ready to intervene at any time, day or night, in case of critical or time-sensitive situations. Early recognition and timely access to care are proven to save lives, and this collaboration is designed to do just that.

About Marani Health
Marani Health is dedicated to enhancing the pregnancy journey for patients and their healthcare teams. Marani’s M•care System and M•other app facilitate seamless screening and monitoring of maternal and fetal health risks to ensure that care is comprehensive, accessible, and convenient. By integrating FDA-cleared connected devices, evidence-based screening tools, and advanced digital communication technologies, Marani Health augments traditional prenatal and postpartum care to improve quality, control excessive costs, and address health inequities. Founded in collaboration with the Mayo Clinic, Marani Health is headquartered in Minneapolis, Minnesota. To learn more, visit https://www.maranihealth.com.

About Ouma Health
Ouma Health is a maternity telehealth company licensed in all 50 states and committed to providing high-quality, accessible prenatal and postpartum care. Ouma’s multidisciplinary team is composed of Maternal-Fetal Medicine physicians, Certified Nurse Midwives, Addiction Medicine providers, Behavioral Health specialists, Lactation Consultants, and nurse navigators. Ouma provides comprehensive maternity telehealth services for health plans/MCOs, hospitals/health systems, healthcare providers, employers, health captives, and third-party reproduction agencies. To learn more, visit oumahealth.com.

Media Inquiries:
todd@maranihealth.com
ali@oumahealth.com

View original content:https://www.prnewswire.com/news-releases/marani-health-and-ouma-health-secure-5-million-cdc-grant-with-the-university-of-wisconsin-madison-to-fund-critical-maternal-and-child-health-research-302272197.html

SOURCE Marani Health, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Turing AI Fellow Jeff Dalton Joins Valence as Head of AI and Chief Scientist

Published

59 mins ago

on

October 10, 2024

By

Jeff Dalton has authored 100+ AI research papers and spent 20 years making search and assistants smarter. Now, he is joining Valence to oversee development of their AI-powered leadership coach—building deeper memory and context for hyper-personalized support that democratizes learning and development.

NEW YORK, Oct. 9, 2024 /PRNewswire-PRWeb/ — Valence, creator of the most widely deployed AI leadership coach for enterprise, today announced the appointment of Dr. Jeff Dalton as Head of AI and Chief Scientist. Jeff will lead ongoing development of Valence’s AI coach Nadia, which is already deployed in dozens of Fortune 500 companies and used by tens of thousands of corporate leaders.

“If we do this right, Nadia will evolve into a personalized AI coach that you can’t work without.”

There are just a handful of people in the world with as much experience as Jeff when it comes to building conversational AI for complex problems. He is the author of more than 100 research papers and holds multiple patents in search, natural language understanding, and question answering. He played a key role on the Knowledge Discovery and Assistant teams at Google, developing language understanding capabilities for the Google Assistant and building next-generation knowledge graphs for Google search. At the University of Glasgow, he led the TREC Conversational Assistance Track (CAsT), which, in partnership with the US National Institute of Standards and Technology, created one of the world’s first benchmarks of conversational search quality.

Today, Jeff holds a UKRI Turing AI Acceleration Fellowship on Neural Conversational Assistants and has received research awards from Google, Amazon, and Bloomberg. He is an Associate Professor in AI at the University of Edinburgh in the School of Informatics, where he leads the Generalized Representation and Information Learning Lab (GRILL).

“The conversational agents we have today aren’t really personal and don’t really adapt to us over the long term,” Jeff explained. “LLMs are amazing technology, but still largely used for simple tasks like writing email or Q&A. How do we create next-generation AI agents that know us well enough to proactively help us with all of our tasks?”

Context is critical, and it’s what sets Valence’s Nadia apart as the only high-context AI work coach. Nadia has extensive context about each employee and the company and uses that to tailor expert guidance to individual employees and situations. At Valence, Jeff will lead development with a focus on building even deeper context and stronger memory for Nadia.

“What I love about Jeff’s background is that his experience is very practical. It’s about taking the research and delivering something valuable for users both immediately and for years down the road. Everyone deserves a great coach, and Jeff will help us deliver personalized, AI-powered support and guidance that creates better leaders and better companies,” said Valence CEO Parker Mitchell.

“Where are you in your career? Where do you want to get to next? What career skills have you learned recently? Context like this will allow Valence’s AI coach to learn about you with each interaction, become a seamless part of workflows, and provide world-class guidance that helps leaders grow. If we do this right, Nadia will evolve into a personalized AI coach that you can’t work without,” said Jeff.

ABOUT VALENCE

Valence is on a mission to unlock human potential across the entire workforce of any organization. Founded in 2018, the company began by offering software to support managers to improve team performance and help teams work better together. In 2022, Valence recognized the potential of LLMs to unlock the ultimate goal of personalized support at scale. They began offering an AI-powered leadership coach that provides individuals with guidance and support unique to their needs, and is affordable enough to scale to every single employee.

Two years on, Valence’s AI coach, Nadia, is the most widely deployed AI leadership coach for enterprise. Nadia integrates seamlessly with company values and leadership frameworks and builds context about each individual employee for personalized learning and development at scale for every career stage. It is technology that puts the world’s best executive coach in the pocket of every leader, manager, and employee.

The company raised its Series A in May 2022, led by Insight Partners.

Media Contact

Kira Luscher, Valence, 1 4154072994, kira@valence.co, https://www.valence.co/

View original content to download multimedia:https://www.prweb.com/releases/turing-ai-fellow-jeff-dalton-joins-valence-as-head-of-ai-and-chief-scientist-302271972.html

SOURCE Valence

Continue Reading

Technology

Hyundai Motor Celebrates Production Milestone of 100 Million Vehicles with ‘One step further’ Exhibition

Published

59 mins ago

on

October 10, 2024

By

Exhibition showcases driving forces behind achieving global production of 100 million vehicles and thanks customers for their unwavering supportJourney begins with first model ‘Cortina Mark 2’ and the Pony, Hyundai Motor’s first independently developed modelThree iconic models ‒ SONATA, ELANTRA and Scoupe – highlight Hyundai’s drive to go ‘one step further’ in design, production and engineeringModern SUV and EV lineups reinforce Hyundai Motor’s transformation from traditional automaker to smart mobility solutions provider

SEOUL, South Korea, Oct. 9, 2024 /CNW/ — Hyundai Motor Company is marking its historic achievement of producing 100 million vehicles worldwide with the grand opening of its ‘One step further’ exhibition at Hyundai Motorstudio Seoul. The exhibition showcases the driving forces behind the 100-million-unit production milestone and conveys Hyundai’s gratitude to those customers who have been part of the journey.

This exhibition is a continuation of the 100 million production celebration held at Hyundai Motor’s Ulsan Plant on September 30. At that event, the company delivered the 100 million and first vehicle, an IONIQ 5, to its new owner, representing the brand’s gratitude to its customers for their unwavering support.

“It takes thousands of parts and pieces to build a car, with combined efforts of millions of people involved in R&D, design and manufacturing over many years,” said Sungwon Jee, Senior Vice President and Global Chief Marketing Officer at Hyundai Motor Company. “We wanted to shed light on these behind-the-scenes efforts that went into producing 100 million vehicles and tell the story of Hyundai Motor’s transformation from a traditional automaker to a leading smart mobility solutions provider.”

Spanning five floors, the exhibition begins on the first floor by introducing the Cortina Mark 2, Hyundai Motor’s first production model; and the Pony, Hyundai Motor’s first independently developed model. The exhibition continues on the second floor where the history of major Hyundai Motor plants is showcased.

The third floor highlights key drivers in achieving the 100 million production milestone, focusing on three iconic models: the first-generation SONATA, the first-generation ELANTRA and Scoupe.

The fourth and fifth floors feature the brand’s modern SUV lineup – SANTA FE, KONA and INSTER; and electric vehicle (EV) lineup – IONIQ 5, IONIQ 5 N and IONIQ 6, looking ahead to Hyundai Motor’s future as it moves forward from a traditional automaker to a smart mobility solutions provider.

Visit Hyundai Newsroom for more information

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyundai-motor-celebrates-production-milestone-of-100-million-vehicles-with-one-step-further-exhibition-302272272.html

SOURCE Hyundai Motor Company

Continue Reading

Technology

Acer Medical: VeriOsteo OP Obtains Medical Device Approval from Indonesia’s Ministry of Health

Published

59 mins ago

on

October 10, 2024

By

TAIPEI, Oct. 10, 2024 /PRNewswire/ — Acer Medical announced that its AI-assisted bone mineral density abnormalities screening software, VeriOsteo OP, has obtained a medical device certificate from Indonesia’s Ministry of Health. This marks the second product to receive registration approval, following the certification of the VeriSee DR, an AI-assisted diagnostic solution for diabetic retinopathy VeriSee DR.

VeriOsteo OP analyzes bone mineral density (BMD) through X-ray images, calculates the bone mineral density (BMD) and to predict T-score and assists doctors in assessing potential BMD abnormalities. The software offers both medical professionals and patients with quick results and appropriate treatment options.

Indonesia has a population of more than 200 million, making it the fourth-largest country in the world. Their elderly population of approximately 16 million is susceptible to abnormal bone density. Due to low awareness of the disease, many forego or delay seeking medical treatment, missing the critical period for early intervention.

Acer Medical, a subsidiary of the Acer Group, specializes in leveraging artificial intelligence (AI) and software development to produce medical imaging devices for early and preventive disease detection. The company is dedicated to developing smart medical software and hardware solutions based on AI-driven medical imaging technologies to enhance the diagnostic process. To date, Acer Medical’s AI medical imaging products have obtained 12 medical device certifications in Taiwan and have been successfully implemented in over 300 medical institutions.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/acer-medical-veriosteo-op-obtains-medical-device-approval-from-indonesias-ministry-of-health-302269784.html

SOURCE Acer Medical Inc.; Acer

Continue Reading

Trending